80.0
Lexeo Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
Assets
(positive)
Change from FY22 to FY25
millions USD
FY22:
FY23:
124
FY24:
126
FY25:
188
(positive)
Change from FY22 to FY25
millions USD
FY22:
17.0
FY23:
15.5
FY24:
20.8
FY25:
80.3
Total assets
Change from FY22 to FY25
millions USD
FY22:
97.1
FY23:
140
FY24:
147
FY25:
269
Liabilities & Equity
(negative)
Change from FY22 to FY25
millions USD
FY22:
14.3
FY23:
17.2
FY24:
22.8
FY25:
16.8
(negative)
Change from FY22 to FY25
millions USD
FY22:
10.6
FY23:
9.03
FY24:
7.25
FY25:
5.21
(positive)
Change from FY22 to FY25
millions USD
FY22:
−113
FY23:
114
FY24:
117
FY25:
247
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
140
FY24:
147
FY25:
269
All amounts in millions USD